Participants 37 96 6
patients with chronic myeloid leukemia in the chronic phase
Participants 233 300 7
patients with chronic myeloid leukemia treated by allogeneic marrow
Participants 317 343 7
while in the chronic phase
Participants 566 586 7
Fifty-seven patients
